Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas

By  

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 781-788

Bentham Science Publishers

Access to resources Recommend Favorite

Pancreatic Adenocarcinoma

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 10, 2007-11 ,pp. : 998-998

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Digoxin and mortality in atrial fibrillation: a prospective cohort study

By Hallberg Pär   Lindbäck Johan   Lindahl Bertil   Stenestrand Ulf   Melhus Håkan  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 959-971

Springer Publishing Company

Access to resources Recommend Favorite

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

By Ko Andrew  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1597-1606

Springer Publishing Company

Access to resources Recommend Favorite

Early risk factors for miscarriage: a prospective cohort study in pregnant women

By Arck Petra C   Rücke Mirjam   Rose Matthias   Szekeres-Bartho Julia   Douglas Alison J   Pritsch Maria   Blois Sandra M   Pincus Maike K   Bärenstrauch Nina   Dudenhausen Joachim W   Nakamura Katrina   Sheps Sam   Klapp Burghard F  

Reproductive BioMedicine Online, Vol. 17, Iss. 1, 2008-07 ,pp. : 101-113

Reproductive Healthcare Ltd

Access to resources Recommend Favorite